相关实验视频

Updated: Jul 12, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.1K

前列腺特异性抗原在前列腺癌中翻倍时间:计算方法和临床影响的综述

Alfonso Romero Crespo1, Daniel Carrasco Gomez, Nestor Manuel Sanchez Martinez

  • 1Hospital Regional Universitario de Málaga: Hospital Regional Universitario de Malaga, Malaga, Spain.

Current opinion in urology
|May 15, 2025
PubMed
概括

前列腺特异性抗原倍增时间 (PSADT) 对于前列腺癌的预后至关重要. 标准化PSADT计算方法和使用验证的工具,如MSKCC计算器可以提高准确性和临床决策.

关键词:
生物化学复发的发生.优秀的计算器计算器测量错误可能是测量错误.前列腺癌是前列腺癌.前列腺特异性抗原的翻倍时间

更多相关视频

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.5K
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

589

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...